Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Programs for Continuing Medical Education: A session; 6. Advances in basic research and therapy of multiple sclerosis].
Inflammatory demyelinating central nervous system diseases in childhood: clinical and paraclinical profiles in 133 patients.
Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.
Investigation of Sequential Growth Factor Delivery during Cuprizone Challenge in Mice Aimed to Enhance Oligodendrogliogenesis and Myelin Repair.
Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis.
Immunity and inflammation in neurodegenerative diseases.
Principal components of functional connectivity: A new approach to study dynamic brain connectivity during rest.
A polymorphism in the resistin gene promoter and the risk of multiple sclerosis.
Is MS an inflammatory or primary degenerative disease?
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: Commentary.
Fulminant inflammatory demyelination: long-term course and magnetic resonance imaging findings.
Cervical cord FMRI abnormalities differ between the progressive forms of multiple sclerosis.
Phase White Matter Signal Abnormalities in Patients with Clinically Isolated Syndrome and Other Neurologic Disorders.
Unmet needs of people with severe multiple sclerosis and their carers: qualitative findings for a home-based intervention.
Month of birth and risk of multiple sclerosis: confounding and adjustments.
Role of T Follicular Helper cells in Multiple Sclerosis.
Control of Macrophage Dynamics as A Potential Therapeutic Approach for Clinical Disorders Involving Chronic Inflammation.
Pregnancy in multiple sclerosis.
A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis.
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance.
Cuprizone does not induce CNS demyelination in nonhuman primates.
Challenges and opportunities in designing clinical trials for neuromyelitis optica.
Glial cells express nuclear nrf2 after fumarate treatment for multiple sclerosis and psoriasis.
Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis.
Characteristics in childhood and adolescence associated with future multiple sclerosis risk in men: cohort study.
Pages
« first
‹ previous
…
538
539
540
541
542
543
544
545
546
…
next ›
last »